Ristimäki A - Search Results

1

Resectability, conversion, metastasectomy and outcome according to RAS and BRAF status for metastatic colorectal cancer in the prospective RAXO study.

Uutela A, Osterlund E, Halonen P, Kallio R, Ålgars A, Salminen T, Lamminmäki A, Soveri LM, Ristamäki R, Lehtomäki K, Stedt H, Heervä E, Muhonen T, Kononen J, Nordin A, Ovissi A, Kytölä S, Keinänen M, Sundström J, Nieminen L, Mäkinen MJ, Kuopio T, Ristimäki A, Isoniemi H, Osterlund P. Uutela A, et al. Among authors: ristimaki a. Br J Cancer. 2022 Sep;127(4):686-694. doi: 10.1038/s41416-022-01858-8. Epub 2022 May 24. Br J Cancer. 2022. PMID: 35610367 Free PMC article. Clinical Trial.

2

[Changing prognosis and treatment of gastric cancer].

Ristamäki R, Salminen P, Kokkola A, Ristimäki A. Ristamäki R, et al. Among authors: ristimaki a. Duodecim. 2010;126(20):2363-71. Duodecim. 2010. PMID: 21125750 Finnish.

3

Prognostic role of CIP2A expression in serous ovarian cancer.

Böckelman C, Lassus H, Hemmes A, Leminen A, Westermarck J, Haglund C, Bützow R, Ristimäki A. Böckelman C, et al. Among authors: ristimaki a. Br J Cancer. 2011 Sep 27;105(7):989-95. doi: 10.1038/bjc.2011.346. Epub 2011 Sep 6. Br J Cancer. 2011. PMID: 21897396 Free PMC article.

4

[Targeted therapy of a cancer patient is multiprofessional collaboration].

Ristimäki A, Kytölä S, Haglund C, Bono P. Ristimäki A, et al. Duodecim. 2013;129(10):1071-9. Duodecim. 2013. PMID: 23767137 Review. Finnish.

5

BRAF mutation in sporadic colorectal cancer and Lynch syndrome.

Thiel A, Heinonen M, Kantonen J, Gylling A, Lahtinen L, Korhonen M, Kytölä S, Mecklin JP, Orpana A, Peltomäki P, Ristimäki A. Thiel A, et al. Among authors: ristimaki a. Virchows Arch. 2013 Nov;463(5):613-21. doi: 10.1007/s00428-013-1470-9. Epub 2013 Aug 21. Virchows Arch. 2013. PMID: 23963522

6

VE1 immunohistochemistry accurately detects BRAF V600E mutations in colorectal carcinoma and can be utilized in the detection of poorly differentiated colorectal serrated adenocarcinoma.

Sajanti S, Sirniö P, Väyrynen JP, Tuomisto A, Klintrup K, Mäkelä J, Ristimäki A, Mäkinen MJ. Sajanti S, et al. Among authors: ristimaki a. Virchows Arch. 2014 Jun;464(6):637-43. doi: 10.1007/s00428-014-1555-0. Epub 2014 Apr 11. Virchows Arch. 2014. PMID: 24722974

7

Heterogeneous EGFR gene copy number increase is common in colorectal cancer and defines response to anti-EGFR therapy.

Ålgars A, Avoranta T, Österlund P, Lintunen M, Sundström J, Jokilehto T, Ristimäki A, Ristamäki R, Carpén O. Ålgars A, et al. Among authors: ristimaki a. PLoS One. 2014 Jun 18;9(6):e99590. doi: 10.1371/journal.pone.0099590. eCollection 2014. PLoS One. 2014. PMID: 24940619 Free PMC article.

8

Prospective immunohistochemical analysis of BRAF V600E mutation in melanoma.

Thiel A, Moza M, Kytölä S, Orpana A, Jahkola T, Hernberg M, Virolainen S, Ristimäki A. Thiel A, et al. Among authors: ristimaki a. Hum Pathol. 2015 Feb;46(2):169-75. doi: 10.1016/j.humpath.2014.08.018. Epub 2014 Oct 30. Hum Pathol. 2015. PMID: 25442222

9

Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer.

Seppälä TT, Böhm JP, Friman M, Lahtinen L, Väyrynen VM, Liipo TK, Ristimäki AP, Kairaluoma MV, Kellokumpu IH, Kuopio TH, Mecklin JP. Seppälä TT, et al. Among authors: ristimaki ap. Br J Cancer. 2015 Jun 9;112(12):1966-75. doi: 10.1038/bjc.2015.160. Epub 2015 May 14. Br J Cancer. 2015. PMID: 25973534 Free PMC article.

10

[Multidisciplinary tailoring of therapy of metastatic colon cancer].

Österlund P, Isoniemi H, Scheinin T, Ristimäki A, Lantto E. Österlund P, et al. Among authors: ristimaki a. Duodecim. 2016;132(12):1177-84. Duodecim. 2016. PMID: 27483635 Review. Finnish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

265 results

Search Page